RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis
Brain · 01.06.2023 · 146 (6) · 2547-2556
DOI: 10.1093/brain/awad046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 15.02.2023. Verfasst von Mahmoud-Reza Rafiee und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Francis Crick Institute, London NW1 1AT, UK. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, European Commission, Francis Crick Institute.
Abstract (Originalsprache)
Valosin-containing protein (VCP) is a hexameric ATPase associated with diverse cellular activities. Genetic mutations in VCP are associated with several forms of muscular and neuronal degeneration, including amyotrophic lateral sclerosis (ALS). Moreover, VCP mediates UV-induced proteolysis of RNA polymerase II (RNAPII), but little is known about the effects of VCP mutations on the transcriptional machinery. Here, we used silica particle-assisted chromatin enrichment and mass spectrometry to study proteins co-localized with RNAPII in precursor neurons differentiated from VCP-mutant or control induced pluripotent stem cells. Remarkably, we observed diminished RNAPII binding of proteins involved in transcription elongation and mRNA splicing in mutant cells. One of these is SART3, a recycling factor of the splicing machinery, whose knockdown leads to perturbed intron retention in several ALS-associated genes. Additional reduced proteins are RBM45, EIF5A and RNF220, mutations in which are associated with various neurodegenerative disorders and are linked to TDP-43 aggregation. Conversely, we observed increased RNAPII binding of heat shock proteins such as HSPB1. Together, these findings shed light on how transcription and splicing machinery are impaired by VCP mutations, which might contribute to aberrant alternative splicing and proteinopathy in neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Francis Crick Institute, London NW1 1AT, UK.
- Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
- UK Dementia Research Institute Centre, King's College London, London, SE5 9RX, UK.
- UCL Genetics Institute, University College London, London, WC1E 6BT, UK.
- Genomics and Regulatory Systems Unit, Okinawa Institute of Science & Technology Graduate University, Okinawa 904-0495, Japan.
ORCID-Profile: Mahmoud-Reza Rafiee
Förderung
- Cancer Research UK
- European Commission
- Francis Crick Institute
- UK Medical Research Council
- Wellcome Trust
- Okinawa Institute of Science & Technology Graduate University
Zitieren
APA
Rafiee, M. R., Rohban, S., Davey, K., Ule, J., & Luscombe, N. M. (2023). RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis. Brain, 146(6), 2547-2556. https://doi.org/10.1093/brain/awad046
Vancouver
Rafiee MR, Rohban S, Davey K, Ule J, Luscombe NM. RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis. Brain. 2023;146(6):2547-2556. doi:10.1093/brain/awad046
BibTeX
@article{Rafiee2023,
author = {Rafiee, Mahmoud-Reza and Rohban, Sara and Davey, Karen and Ule, Jernej and Luscombe, Nicholas M},
title = {RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis},
journal = {Brain},
year = {2023},
volume = {146},
number = {6},
pages = {2547--2556},
doi = {10.1093/brain/awad046}
}
EUVIMED